Breaking News Instant updates and real-time market news.

SPHS

Sophiris Bio

$2.74

0.13 (4.98%)

16:07
08/14/18
08/14
16:07
08/14/18
16:07

Sophiris Bio reports Q2 EPS (20c), consensus (15c)

Reports Q2 revenue $0, consensus $0.

SPHS Sophiris Bio
$2.74

0.13 (4.98%)

06/26/18
PIPR
06/26/18
NO CHANGE
Target $7
PIPR
Overweight
Sophiris Bio 'worth sticking with' after patient death, says Piper Jaffray
Piper Jaffray analyst Christopher Raymond maintained an Overweight rating and $7 price target on Sophiris Bio following disclosure of Phase 2b topsalysin data in localized prostate cancer. In a research note to investors, Raymond contended that while a patient death is "never a great headline," and that death after retreatment has now placed a cloud over the program, he thinks there is a good chance this incident may end up not being categorized as drug-related, and thinks it's worth "sticking with it here." Raymond sees a "credible" path forward with single administration, and urges investors to be patient on the name as clarity on the death and clinical path come more into focus.
06/25/18
PIPR
06/25/18
NO CHANGE
Target $7
PIPR
Overweight
Piper says Sophiris Bio 'worth sticking with' despite patient death in trial
A patient death after retreatment has "placed a cloud" over Sophiris Bio's topsalysin program despite efficacy data that was "clearly a home run," according to Piper Jaffray analyst Christopher Raymond. He sees a good chance the incident may end up not being categorized as drug-related, noting that topsalysin previously had shown a "pristine safety profile," and Raymond thinks the stock is "worth sticking with" at this point. The analyst, who is reserving judgment until more detail on topsalysin's role in the death is available, thinks there remains a credible path forward even if the death is deemed drug related. He keeps an Overweight rating and $7 price target on Sophiris shares, which fell about 40% to $2.24 today.
06/25/18
MAXM
06/25/18
NO CHANGE
MAXM
Sophiris Bio's topsalysin remains a vaible PC drug candidate, says Maxim
Maxim analyst Jason McCarthy said Buy rated Sophiris Bio shares are being pressured by a patient death, which the cause remains unknown. The analyst said the data for single administration is positive and there have bee no safety issues. McCarthy continues to believe that topsalysin remains a viable PC drug candidate, but notes we have to wait on repeat administration data later in 2018 and a report on the patient.
06/25/18
HCWC
06/25/18
NO CHANGE
Target $4.3
HCWC
Buy
Sophiris Bio price target cut to $4.30 from $6 at H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis lowered his price target on Sophiris Bio to $4.30 from $6 and maintained a Buy rating on shares after the company announced top-line interim safety and biopsy data following a single administration of topsalysin from its ongoing open-label Phase 2b clinical trial. In a research note to investors, the analyst noted that the study demonstrated that a single administration of topsalysin promoted a clinical response, with 29% of treated patients showing clinical responses at six months of follow up, but added that the company was recently notified that one subject died on the same day after the second administration of topsalysin. The company is currently investigating the cause of death, with no information currently, and no additional patients are receiving a second topsalysin dose. While today's data is "impressive," Pantginis said the patient death has placed a cloud over the story until there is more information, and future scenarios may include a clinical hold on topsalysin by the FDA or the patient death is deemed unrelated to the drug, leading to the study continuing as planned.

TODAY'S FREE FLY STORIES

CSTR

CapStar Financial

$15.40

-0.37 (-2.35%)

16:36
04/25/19
04/25
16:36
04/25/19
16:36
Hot Stocks
CapStar Financial increases quarterly dividend »

CapStar Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 05

    Jun

MAT

Mattel

$12.30

-0.25 (-1.99%)

16:35
04/25/19
04/25
16:35
04/25/19
16:35
Hot Stocks
Breaking Hot Stocks news story on Mattel »

Mattel reports Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 16

    May

  • 12

    Jun

CVA

Covanta

$17.26

-0.16 (-0.92%)

16:35
04/25/19
04/25
16:35
04/25/19
16:35
Earnings
Covanta reports Q1 EPS 3c, consensus (18c) »

Reports Q1 revenue $453M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 05

    May

  • 09

    May

  • 05

    Jun

FIX

Comfort Systems USA

$56.64

-1.13 (-1.96%)

16:35
04/25/19
04/25
16:35
04/25/19
16:35
Hot Stocks
Comfort Systems USA raises quarterly dividend 0.5c per share to 10c »

Comfort Systems USA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 21

    May

  • 05

    Jun

  • 12

    Jun

  • 13

    Jun

TLCC

Twinlab

$0.00

(0.00%)

16:35
04/25/19
04/25
16:35
04/25/19
16:35
Hot Stocks
Twinlab appoints Carla Goffstein CFO »

Twinlab Consolidated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CUBE

CubeSmart

$31.44

-0.02 (-0.06%)

16:34
04/25/19
04/25
16:34
04/25/19
16:34
Hot Stocks
CubeSmart sees FY19 EPS 85c-89c, consensus 80c »

"With our January…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 14

    May

ASB

Associated Banc-Corp

$22.23

-0.15 (-0.67%)

16:34
04/25/19
04/25
16:34
04/25/19
16:34
Earnings
Associated Banc-Corp reports Q1 EPS 50c, consensus 50c »

Net interest margin of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    Apr

  • 01

    May

  • 19

    Jun

SPSC

SPS Commerce

$102.41

0.16 (0.16%)

16:34
04/25/19
04/25
16:34
04/25/19
16:34
Earnings
SPS Commerce raises FY19 adj. EPS view to $2.16-$2.22 from $2.03-$2.09 »

Consensus $2.09. Sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 06

    May

  • 07

    May

  • 14

    May

  • 28

    May

  • 05

    Jun

FIX

Comfort Systems USA

$56.64

-1.13 (-1.96%)

16:34
04/25/19
04/25
16:34
04/25/19
16:34
Earnings
Comfort Systems USA reports Q1 EPS 53c, consensus 51c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 21

    May

  • 05

    Jun

  • 12

    Jun

  • 13

    Jun

MSBI

Midland States

$26.22

-0.21 (-0.79%)

16:33
04/25/19
04/25
16:33
04/25/19
16:33
Earnings
Midland States reports Q1 EPS 57c, consensus 57c »

Book value per share…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 03

    May

EHC

Encompass Health

$62.86

0.54 (0.87%)

16:33
04/25/19
04/25
16:33
04/25/19
16:33
Earnings
Encompass Health backs FY19 adjusted EPS view $3.71-$3.85, consensus $3.77 »

Backs FY19 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 03

    May

  • 05

    Jun

CELG

Celgene

$93.93

0.82 (0.88%)

16:32
04/25/19
04/25
16:32
04/25/19
16:32
Earnings
Celgene backs FY19 adj. EPS view $10.60-$10.80, consensus $10.70 »

Backs FY19 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Apr

  • 04

    May

  • 18

    May

  • 31

    May

  • 27

    Jun

  • 03

    Sep

JOE

Saint Joe Co.

$17.38

0.04 (0.23%)

16:32
04/25/19
04/25
16:32
04/25/19
16:32
Hot Stocks
Saint Joe Co. executed lease for new office in Panama City Beach, FL »

The St. Joe Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

EHC

Encompass Health

$62.86

0.54 (0.87%)

16:32
04/25/19
04/25
16:32
04/25/19
16:32
Earnings
Encompass Health reports Q1 adjusted EPS $1.04, consensus 89c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 03

    May

  • 05

    Jun

CUBE

CubeSmart

$31.44

-0.02 (-0.06%)

16:32
04/25/19
04/25
16:32
04/25/19
16:32
Earnings
CubeSmart reports Q1 EPS 19c, consensus 19c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 14

    May

SPSC

SPS Commerce

$102.41

0.16 (0.16%)

16:31
04/25/19
04/25
16:31
04/25/19
16:31
Earnings
SPS Commerce sees Q2 adj. EPS 51c-53c, consensus 51c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 06

    May

  • 07

    May

  • 14

    May

  • 28

    May

  • 05

    Jun

TBNK

Territorial Bancorp

$28.35

-0.3 (-1.05%)

16:31
04/25/19
04/25
16:31
04/25/19
16:31
Earnings
Territorial Bancorp reports Q1 EPS 70c, consensus 49c »

Net interest income…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

CELG

Celgene

$93.93

0.82 (0.88%)

16:31
04/25/19
04/25
16:31
04/25/19
16:31
Earnings
Celgene reports Q1 adjusted EPS $2.55, consensus $2.43 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Apr

  • 04

    May

  • 18

    May

  • 31

    May

  • 27

    Jun

  • 03

    Sep

SPSC

SPS Commerce

$102.41

0.16 (0.16%)

16:30
04/25/19
04/25
16:30
04/25/19
16:30
Earnings
SPS Commerce reports Q1 adj. EPS 60c, consensus 51c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 06

    May

  • 07

    May

  • 14

    May

  • 28

    May

  • 05

    Jun

SHBI

Shore Bancshares

$15.05

-0.035 (-0.23%)

16:30
04/25/19
04/25
16:30
04/25/19
16:30
Earnings
Shore Bancshares reports Q1 cont-op EPS 30c, consensus 29c »

Reports Q1 net interest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOGM

LogMeln

$84.32

0.085 (0.10%)

16:30
04/25/19
04/25
16:30
04/25/19
16:30
Earnings
LogMeln sees FY19 EPS $4.96-$5.02, consensus $4.94 »

Sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

16:30
04/25/19
04/25
16:30
04/25/19
16:30
Options
Preliminary option volume of 19.0M today »

Preliminary option volume…

ENVA

Enova International

$26.53

0.78 (3.03%)

16:29
04/25/19
04/25
16:29
04/25/19
16:29
Earnings
Enova International sees FY19 adjusted EPS $3.17-$3.82, consensus $3.06 »

Sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 07

    May

  • 09

    May

  • 30

    May

  • 13

    Nov

GCI

Gannett

$9.26

-0.11 (-1.17%)

16:29
04/25/19
04/25
16:29
04/25/19
16:29
Hot Stocks
MNG modifies slate of director nominees for Gannett board »

MNG Enterprises, owner…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 16

    May

FHB

First Hawaiian

$26.78

-0.26 (-0.96%)

16:29
04/25/19
04/25
16:29
04/25/19
16:29
Earnings
First Hawaiian reports Q1 core EPS 53c, consensus 52c »

Reports Q1 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.